Site notifications

Sub menu

 

 

Cancellations and suspensions

This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.

Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.

Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.

The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.

The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.

To find out whether a product is currently authorised for supply in Australia, check the ARTG.

Last updated
Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Action

Date of effect

Find out more about Cancellations and Suspensions.

1881 result(s) found, displaying 1851 to 1875

  • Lubricant, eye [44237] (Cancelled under s.41GN(1)(c))

    Cancellation or suspension
    Regulatory action due to As the sponsor of the kind of medical device failed to comply with the notice under s.41JA of the Act, requesting the sponsor to give the TGA information relating to the kind of device, within a further 10 working days from the day specified in the notice, the entry was cancelled., effective 01/10/2013

  • Endotherapy, forceps (Cancelled under s.41GN(1)(b) and (f))

    Cancellation or suspension
    Regulatory action due to As the kind of medical device included in the Register was not correctly classified, the certification made under s.41FD(c) was incorrect.As the sponsor was not identified in the product information, the sponsor failed to comply with a condition of inclusion imposed under s. 41FO.As the information supplied with the device did not comply with the essential principles, the certification made under s.41FD(d) was incorrect.As the sponsor failed to provide evidence that an appropriate conformity assessment procedure has been applied to the device, the certification made under s.41FD(f) was incorrect., effective 30/09/2013

  • TOTALCARE (Cancelled under s30(2)(a) and (ba) and 30(1A)(a))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product, the medicine was not safe for the purposes for which it is to be used and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(b), (c) and (j) were incorrect. The goods were also not eligible for listing as the indication was for the treatment of a condition specified in Part 2 of Appendix 6 to the TGAC (see item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations)., effective 27/09/2013

  • Compress, hot/cold pack, reusable (Cancelled under s.41GN(1)(f))

    Cancellation or suspension
    Regulatory action due to As the device labelling did not comply with the essential principles, the certification made under s.41FD (d) was incorrect.As the sponsor failed to provide evidence that conformity assessment procedure has been applied to the device, the certifications made under s.41FD(f) and (g) were incorrect.As the promotional material did not comply with the Therapeutic Goods Advertising Code 2007, the certification made under s.41FD(h) was incorrect., effective 24/09/2013

  • CAD/CAM unit, orthopaedic [41018] (Cancelled under s.41GN(1)(f))

    Cancellation or suspension
    Regulatory action due to As the sponsor failed to provide evidence that an appropriate conformity assessment procedure has been applied to the device, the certification made under s.41FD(f) was incorrect., effective 23/09/2013

  • Gauge, depth, dental implant (Cancelled under s.41GN(1)(f))

    Cancellation or suspension
    Regulatory action due to As the sponsor failed to provide evidence that an appropriate conformity assessment procedure has been applied to the device, the certification made under s.41FD (f) and (g) were incorrect., effective 20/09/2013

  • Suction tip, general-purpose, single use (Cancelled under s.41GN(1)(b) and (f))

    Cancellation or suspension
    Regulatory action due to As the kind of medical device included in the Register was not correctly classified, the certification made under s.41FD(c) was incorrect.As the device labelling did not comply with the essential principles, the certification made under s.41FD(d) was incorrect.As the sponsor was not identified in the product information, the sponsor failed to comply with a condition of inclusion imposed under s.41FO.As the sponsor failed to supply evidence that conformity assessment procedures have been applied to the device, the certifications made under s.41FD(f) and (g) were incorrect., effective 13/09/2013

  • Cryogenic spray, cutaneous (Cancelled under s.41GN(1)(f))

    Cancellation or suspension
    Regulatory action due to As the kind of medical device included in the Register was not correctly classified, the certification made under s.41FD(c) was incorrect., effective 31/08/2013

  • GanoMax (Cancelled under s30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(c) and (j) were incorrect., effective 16/08/2013

  • LLP - Mask, air/oxygen (Cancelled under s. 41GN(1)(f))

    Cancellation or suspension
    Regulatory action due to As the kind of medical device included in the Register was not correctly classified and the sponsor failed to provide evidence that an appropriate conformity assessment procedure has been applied to the device, the certifications made under s.41FD(c) and (f) were incorrect., effective 05/08/2013

  • Zenacor (Cancelled under s30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(c) and (j) were incorrect. The goods also did not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 05/07/2013

  • COFFEE SHAPE slimming green coffee (Cancelled under s30(1C))

    Cancellation or suspension
    Regulatory action due to The sponsor failed to comply within the required timeframe with a notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 02/07/2013

  • Stophair-Hair Inhibiting Spray (Cancelled under s30(1C))

    Cancellation or suspension
    Regulatory action due to The sponsor failed to comply within the required timeframe with a notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 28/06/2013

  • Vitamax Calcium 600mg + Vitamin D (Cancelled under s30(1A)(a) s30(2)(b), (ba) and (c))

    Cancellation or suspension
    Regulatory action due to The goods: are not eligible for listing as the indication was for the treatment of a condition specified in Part 2 of Appendix 6 to the TGAC (see item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations); have changed so that they have become separate and distinct from the goods in the ARTG. The sponsor has failed to comply with a condition of listing under s28(5)(ab) (that the goods would not advertise the goods for an indication other than those accepted in the Register). The certification under s26A(2)(c) (that the presentation of the goods is not unacceptable) is incorrect., effective 14/06/2013

  • Vitamax Calcium 600mg (Cancelled under s30(1A)(a) and s30(2)(c))

    Cancellation or suspension
    Regulatory action due to The goods are not eligible for listing as the indication was for the treatment of a condition specified in Part 2 of Appendix 6 to the TGAC (see item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations). The sponsor has failed to comply with a condition of listing under s28(5)(ab) (that the goods would not advertise the goods for an indication other than those accepted in the Register)., effective 14/06/2013

  • Inner Health Candex (Cancelled under s.30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect.The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 17/05/2013

  • Myadec Primetime 50+ Formulation (Cancelled under s.30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect. The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 08/05/2013

  • Swisse Ultiboost Appetite Suppressant (Cancelled under s. 30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect., effective 04/04/2013

  • Fat Eliminator (Cancelled under 30(2)(ba) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect (paragraph 30(2)(ba)). The goods also did not conform to regulatory requirements relating to advertising (paragraph 30(2)(e)., effective 25/02/2013

  • Energy Slim (Cancelled under Section 30 (1C))

    Cancellation or suspension
    Regulatory action due to Sponsor failed to comply with notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 04/01/2013

  • Undoit Plus (Cancelled under 30(2)(ba), (c) and (e))

    Cancellation or suspension
    Regulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect. Failed to comply with a condition of listing under s.28(5)(ab) of the Act., effective 11/12/2012
Last updated